Development of Indicators for Quality Drug Use in Elderly Patients in Community Hospitals Based on Adverse Health Outcomes and the Beers Criteria
Main Article Content
Abstract
Objective: To determine associations between polypharmacy and adverse health outcomes in elderly patients and develop quality indicators for medication use in elders in community hospitals. Methods: This study was a mixed-method design divided into two phases. The first phase was a quantitative retrospective cohort study of 7,702 elderly patients who received outpatient services at Nong Han Hospital between October 2023 and June 2024. Data from the HosXp version 4 system was used to determine associations between polypharmacy and the four adverse health outcomes including readmission within 48 hours, visiting the hospital before the appointment date, hospitalization within 3 months, and in-hospital mortality within 6 months. The second phase was a qualitative study using a modified Delphi technique to develop quality indicators for medication use in elderly patients. The study involved 17 experts consisting of 7 physicians, 8 pharmacists, and 2 nurses. Results: The polypharmacy group (6-9 medications) and excessive polypharmacy group (≥10 medications) were significantly associated with visiting the hospital before the appointment date (RR = 1.6, 95% CI: 1.5, 1.8 and RR = 1.7, 95% CI: 1.5, 1.9 respectively) and rehospitalization within 3 months (RR = 2.8, 95% CI: 2.0, 3.9 and RR = 5.6, 95% CI: 3.8, 8.2 respectively). Cardiovascular diseases, respiratory diseases, and kidney and reproductive system diseases were significantly associated with adverse health outcomes. The development of quality indicators for medication uses in elderly patients resulted in fourteen indicators accepted by the experts. Conclusion: Polypharmacy in the elderly is associated with adverse health outcomes, especially in certain chronic disease groups. The developed quality indicators for medication use can be applied to assess and improve the quality of medication use in elderly patients in community hospitals. However, further studies are needed to confirm the effectiveness of these indicators in real-world situations and to further develop them to better suit the context of Thailand.
Article Details

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
ผลการวิจัยและความคิดเห็นที่ปรากฏในบทความถือเป็นความคิดเห็นและอยู่ในความรับผิดชอบของผู้นิพนธ์ มิใช่ความเห็นหรือความรับผิดชอบของกองบรรณาธิการ หรือคณะเภสัชศาสตร์ มหาวิทยาลัยสงขลานครินทร์ ทั้งนี้ไม่รวมความผิดพลาดอันเกิดจากการพิมพ์ บทความที่ได้รับการเผยแพร่โดยวารสารเภสัชกรรมไทยถือเป็นสิทธิ์ของวารสารฯ
References
Office of the National Economic and Social Development Council. Population projections for Thailand 2010–2040 (revised edition). Bangkok: Office of the National Economic and Social Development Council; 2019. p. 3-21.
Khezrian M, McNeil CJ, Murray AD, Myint PK. An overview of prevalence, determinants, and health outcomes of polypharmacy. Ther Adv Drug Saf 2020; 11: 2042098620933741.
Maher RL, Hanlon J, Hajjar ER. Clinical consequences of polypharmacy in elderly. Expert Opin Drug Saf 2014; 13: 57-65.
Salvi F, Rossi L, Lattanzio F, Cherubini A. Is polypharmacy an independent risk factor for adverse outcomes after an emergency department visit? Intern Emerg Med 2017; 12: 213-20.
Varavithya V, Tirapat C, Rojpibulstit P, Bhurayanon tachai P, Pratipanawatr T. Potentially inappropriate medication use and the hospitalization rate among Thai elderly patients: a retrospective cohort study. Eur J Clin Pharmacol 2022; 78: 847-55.
Saengsawang S, Limwattananon S. Drug use in patients with non-communicable chronic diseases and health outcomes in Nonghan Hospital, Udonthani. Thai Journal of Pharmacy Practice 2020 ; 12: 271-86.
Vatcharavongvan P, Puttawanchai V. Potentially inappropriate medications among the elderly in primary care in Thailand from three different sets of criteria. Pharm Pract (Granada). 2019; 17: 1494.
Hsu CC, Sandford BA. The Delphi technique: Making sense of consensus. Pract Assess Res Eval 2007; 12: 10. doi.org/10.7275/pdz9-th90
Eubank BH, Mohtadi NG, Lafave MR, Wiley JP, Bois AJ, Boorman RS, et al. Using the modified Delphi method to establish clinical consensus for the diagnosis and treatment of patients with rotator cuff pathology. BMC Med Res Methodol 2016; 16: 56.
Masnoon N, Shakib S, Kalisch-Ellett L, Caughey GE. What is polypharmacy? A systematic review of definitions. BMC Geriatr 2017; 17: 230.
Vatcharavongvan P, Prasert V, Ploylearmsang C, Puttawanchai V. Potentially inappropriate medica- tion use among geriatric patients in primary health care centers by applying the list of risk drugs for Thai elderly criteria. J Public Health Dev. 2021; 19: 58-70.
Zhang Y, Chen Z, Tian F. Potentially inappropriate medications in older Chinese outpatients based on the Beers criteria and Chinese criteria. Front Pharmacol 2022; 13: 991087.
Hill-Taylor B, Sketris I, Hayden J, Byrne S, O'Sullivan D, Christie R. Application of the STOPP/START criteria: a systematic review of the prevalence of potentially inappropriate prescribing in older adults, and evidence of clinical, humanistic and economic impact. J Clin Pharm Ther 2013; 38: 360-72.
Prasert V, Akazawa M, Shono A, Chanjaruporn F, Ploylearmsang C, Muangyim K, Wattanapongsatit T, Sutin U. Applying the Lists of Risk Drugs for Thai Elderly (LRDTE) as a mechanism to account for patient age and medicine severity in assessing potentially inappropriate medication use. Res Social Adm Pharm 2018; 14: 451-8. doi: 10.1016/j.sapharm.2017.05.012.
Limpawattana P, Kamolchai N, Theeramnut A, Pimporm J. Potentially inappropriate prescribing of Thai older adults in an internal medicine outpatient clinic of a tertiary care hospital. Afr J Pharm Pharmacol 2013; 7: 2417-22.
Campbell SM, Braspenning J, Hutchinson A, Marshall M. Research methods used in developing and applying quality indicators in primary care. Qual Saf Health Care, 2002: 11: 358–64. doi.org/10.1136/qhc.11.4.358
Fick DM, Cooper JW, Wade WE, Waller JL, Maclean JR, Beers MH. Updating the Beers criteria for potentially inappropriate medication use in older adults. Arch Intern Med 2003; 163: 2716–24. doi.org/10.1001/archinte.163.22.2716
O'Mahony D, O'Sullivan D, Byrne S, O'Connor MN, Ryan C, Gallagher P. STOPP/START criteria for potentially inappropriate prescribing in older people: version 2. Age Ageing 2015; 44: 213–18. doi.org/10.1093/ageing/afu145
Zhang J, Yu KF. What's the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes. JAMA 1998; 280: 1690-1. doi.org/10.1001/jama.280.19.1690.